Skip to content

CONNECTING LEADERS

In Science And Business

WHO WE ARE

The Life Sciences Collaborative is a select group of industry veterans and executives from the pharmaceutical, biotechnology, and medical device sectors and industry service providers who share a common vision of increasing the success.

LSC activities are built around small, informal, monthly breakfast educational and networking meetings. These sessions focus on topics around innovation and investment, including industry trends, practical issues related to growing and managing innovative businesses, and best practices.

OUR PARTNERS

MISSON STATEMENT

The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professionals.

LSC is a volunteer organization. It is neither sponsorship nor membership dues driven. If you are interested in participating in LSC’s monthly breakfast meetings, please contact us.

MISSON STATEMENT

The mission of the Life Sciences Collaborative is to promote connectivity among leaders in emerging life sciences businesses through networking, education, training, and mentorship with the goal of advancing professional.

LSC EVENTS

The meetings also include presentations by emerging companies, providing them with
opportunities to get expert feedback on their technologies and to expand their networks.

No event found!
Load More

LSC MEMBERS

CEOs, Directors, Private Equity and Venture Partners, Angel Investors

Members may have successful track record leading public or private companies.

Maria L. Maccecchini, PhD

Position: Founder, President & Chief Executive Officer, Annovis
Categories: 3. MEMBERS, LSC – New Jersey

Maria L. Maccecchini, PhD

Founder, President & Chief Executive Officer, Annovis

Mark Connell

Position: President & Co-Founder, SLBST Pharma
Categories: 3. MEMBERS, Boston, MA

Mark Connell

President & Co-Founder, SLBST Pharma

Mark Moody

Position: Activate Therapeutics, LLC
Categories: 2. PLANNING COMMITTEE, 3. MEMBERS, Boston, MA

Mark Moody

Activate Therapeutics, LLC

Mark Tepper, Ph.D

Position: EuMentis Therapeutics
Categories: 2. PLANNING COMMITTEE, 3. MEMBERS, Boston, MA

Mark Tepper, Ph.D

EuMentis Therapeutics

Matthew Handel

Position: CEO of ExpressCells, and Board Director.
Categories: 3. MEMBERS, LSC – New Jersey

Matthew Handel

CEO of ExpressCells, and Board Director.

Michael Cardone, PhD

Position: CEO of Eutropics Pharmaceuticals, Inc
Categories: 3. MEMBERS, Boston, MA

Michael Cardone, PhD

CEO of Eutropics Pharmaceuticals, Inc

Michael Magliochetti, Ph.D

Position: Riverside Partners
Categories: 2. PLANNING COMMITTEE, 3. MEMBERS, Boston, MA

Michael Magliochetti, Ph.D

Riverside Partners

Michael Romano

Position: Partner - Life Science Industry Practice Group at RSM US LLP
Email: Michael.Romano@rsmus.com
Categories: 1. CO-CHAIR, 2. PLANNING COMMITTEE, 3. MEMBERS, Pennsylvania

Michael Romano

Partner - Life Science Industry Practice Group at RSM US LLP

Michael Wiley

Position: Vice President, Foundation Venture Capital Group, LLC
Categories: 1. CO-CHAIR, LSC – New Jersey

Michael Wiley

Vice President, Foundation Venture Capital Group, LLC

Michael Webb

Position: Enveric Biosciences Inc.
Categories: 3. MEMBERS, Boston, MA

Michael Webb

Enveric Biosciences Inc.

Mike Daley, Ph.D

Position: OrthogenRX
Categories: 3. MEMBERS, 3. MEMBERS, 3. MEMBERS, Boston, MA, LSC – New Jersey, Pennsylvania

Mike Daley, Ph.D

OrthogenRX

Mohan Kabadi, Ph.D

Position: Co-Founder, Managing Partner, Therabiome, LLC
Categories: 2. PLANNING COMMITTEE, LSC – New Jersey

Mohan Kabadi, Ph.D

Co-Founder, Managing Partner, Therabiome, LLC

Nancy Briefs

Position: Altrix Bio
Categories: 3. MEMBERS, Boston, MA

Nancy Briefs

Altrix Bio

Norelle Wildburger

Position: BioPharma R&D | Biotech | Life Sciences | Innovative
Categories: 3. MEMBERS, LSC – New Jersey

Norelle Wildburger

BioPharma R&D | Biotech | Life Sciences | Innovative

Pam Layton

Position: Chief Executive Officer at 4Immune Therapeutics
Categories: 3. MEMBERS, Boston, MA

Pam Layton

Chief Executive Officer at 4Immune Therapeutics

Peter Rock

Position: LeviSense Medical
Categories: 2. PLANNING COMMITTEE, 3. MEMBERS, Boston, MA

Peter Rock

LeviSense Medical

Peter Schiemann

Position: CEO & Chairman @Ymmunobio & Managing Partner @Widler & Schiemann Ltd
Categories: 3. MEMBERS, LSC – New Jersey

Peter Schiemann

CEO & Chairman @Ymmunobio & Managing Partner @Widler & Schiemann Ltd

Patrick Dentinger

Position: CEO CellPort Software
Email: Pdentinger@cellportaoftware.com
Categories: 3. MEMBERS, Pennsylvania

Patrick Dentinger

CEO CellPort Software

Pnina Mintz, PhD

Position: Executive Leaders for Advisory Boards (ELAB)
Categories: 3. MEMBERS, LSC – New Jersey

Pnina Mintz, PhD

Executive Leaders for Advisory Boards (ELAB)

Poul Strange, MD, PHD

Position: President Integrated Medical Development
Categories: 3. MEMBERS, LSC – New Jersey

Poul Strange, MD, PHD

President Integrated Medical Development

WHAT OUR MEMBERS SAY

“The LSC has given me instant access to a number of subject matter experts as well new connections to colleagues up and down the East Coast!”

Mike Webb
President and CEO, CXL Ophthalmics

“I learn something new and valuable at every LSC event. I’ve been able to make new connections & friends in every aspect of the ecosystem.” 

Mark Moody PhD
COO, Activate Therapeutics

“I learn something new and valuable at every LSC event. I’ve been able to make new connections & friends in every aspect of the ecosystem.” 

Mark Moody PhD
COO, Activate Therapeutics